Here is what a couple of contracted clinicians had to say about why they decided to contract to join the certified Biologix Hair Therapy Center team:
Dr. Allan Patrick, Director of Atlantic Hair Restoration said, "We see a lot of consultations for hair loss issues, and not all patients are candidates for hair transplantation. Many have milder cases that are not well treated with traditional medical or topical laser therapy. I have been waiting for an effective minimally invasive therapy for mild-moderate hair loss. At the ISHRS annual meeting in Nassau, I was excited to learn of the potential to treat this segment of my patient population with the new product coming from Biologix. I am anxious to be one of the first to use this exciting new product, and to be a regional distributor."
Dr. Richard S. Wilkinson of the Wilkinson Wellness Clinic said, "As a physician who has been practicing integrative and anti-aging medicine for many years, I find the Biologix Hair opportunity a wonderful offer.
"In Anti-Aging Medicine, or, as some would describe the field, Age Management Medicine, our primary goal is to help our patients achieve and maintain high-level wellness. Another aspect of aging that deserves attention is the aesthetics of an older person. Typically we feel better if we think we look good. And for some aging folk, the hair status is a very big deal. We feel that we look more sickly when we have lost substantial amounts of our hair. When we feel better, we want to look better.
"Biologix Hair offers an opportunity to help our aging population, whether 25 years old or 75 years, experience a higher level of overall wellness both inside and outside. I believe our patients will appreciate the opportunity to complement their internal improvements with external, visual improvements.
"Another important and practical reason for my interest is the political status of medical practice. We, certainly I, have little idea of the future impact of the so-called Obamacare scheme on the viability of my private practice. It seems to me that Biologix Hair could provide a method of financial viability during a time of economic turmoil upcoming in the field of medicine."
About Biologix Hair Inc. and Biologix Hair Science Ltd.
Biologix Hair Inc. (Biologix Hair), together with its wholly owned biotechnology subsidiary, Biologix Hair Science Ltd. (BHS), is focused on realizing the full market potential for its patent-pending hair loss formula - Biologix Revive - and its demonstrated ability to prevent and reverse the effects of alopecia, which plagues hundreds of millions worldwide.
Between mid-2004 and mid-2012, more than 30,000 pre-clinical-trial treatments of Biologix Revive were administered to 5,000-plus patients in South America suffering with varying degrees of alopecia, as well as people seeking preventive treatment. The participating treatment clinicians subjectively observed and reported that virtually 100% of preventive care clients continued to retain their healthy hair and an estimated 80-85% of the males and 90-plus% of the females treated for hair regeneration experienced significant regrowth of their own natural hair. And among alopecia areata patients, virtually total hair regrowth was observed in 100% of the cases. To date, no negative side effects have been reported.
BHS is currently focused on obtaining FDA approval for its breakthrough hair loss prevention and regeneration therapy and has initiated a research and development program with one of the world's leading medical research universities, the Beijing Institute of Technology (BIT). The R&D program, expected to take approximately twelve months to complete, is an important final step before formal clinical trials and the FDA approval process begins.
Most Popular Stories
- Bipartisan Budget Deal Gets Key Support in House
- Bitcoin Clones Lurch Onto Financial Scene
- Clinton to Keynote Annual Simmons Leadership Conference
- GM to Stop Making Autos in Australia
- Selena Gomez, Shakira Among Top Hispanic Searches
- PhD Project Grooms Business Profs
- How Bitcoin and Other Cryptocurrencies Work
- It's Primary Time in Texas
- How to Survive a Subzero Stranding
- Pacific Trade Pact Delay Hinders U.S. Pivot to Asia